Clinical Trial Update: A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 safety trial of NNC6989-0001 is currently recruiting in adults with overweight or obesity. The study is sponsored by Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NNC6989-0001

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 1 | Status: RECRUITING